Zhao · Acta biomaterialia 2022 · Preclinical animal and in vitro laboratory study · n=?

A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.

Cited 37 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical bench and animal (rat) study with no human data

PubMed 35245681 · doi:10.1016/j.actbio.2022.02.039 · record verified 2026-08-27

What was done

Researchers developed a negatively charged double-network hydrogel (PMSP) composed of maleimided and thiolated gamma-polyglutamic acid crosslinked via thiol-maleimide and self-oxidized thiols. The hydrogel was loaded with the tripeptide drug KPV (Lys-Pro-Val) via electrostatic interactions. In vitro assays evaluated hydrogel rheological properties, thermal stability of KPV at 50 degrees Celsius, and adhesion to inflamed versus healthy tissue-mimicking substrates. In vivo experiments evaluated mucosal adhesion via imaging, therapeutic alleviation, colonic epithelial barrier recovery, and gut microbiota changes following intracolonic delivery in a rat model of TNBS-induced ulcerative colitis.

What was found

PMSP exhibited a storage modulus (G') of 17.6 Pa and a linear viscoelastic region of 107.2% strain. Bio-adhesive force was higher toward inflamed tissue-mimicking substrates than healthy counterparts, and in vivo imaging confirmed selective adherence to inflamed colonic mucosa in rats. PMSP maintained KPV stability at 50 degrees Celsius. In rats with TNBS-induced colitis, intracolonic PMSP-KPV improved colitis alleviation, restored the colonic epithelial barrier, and increased the abundance of beneficial gut microorganisms. Quantitative numerical endpoints for in vivo disease activity, barrier recovery, and microbiome shifts were not reported in the abstract.

Why it matters

This study demonstrates a targeted hydrogel delivery system that preferentially adheres to inflamed colonic mucosa and stabilizes peptide therapeutics for mucosal healing.

Limits

The investigation is limited to in vitro assays and a chemically induced rat colitis model, which does not capture the full chronicity of human ulcerative colitis. The abstract omits sample sizes (n), exact numerical effect sizes, statistical significance values for in vivo outcomes, and evaluations of long-term hydrogel safety or degradation.

Cited by